{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,12]],"date-time":"2026-05-12T08:16:28Z","timestamp":1778573788636,"version":"3.51.4"},"reference-count":38,"publisher":"MDPI AG","issue":"10","license":[{"start":{"date-parts":[[2026,5,10]],"date-time":"2026-05-10T00:00:00Z","timestamp":1778371200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100002767","name":"the Natural Science Foundation of Hunan Province","doi-asserted-by":"publisher","award":["2023JJ60459"],"award-info":[{"award-number":["2023JJ60459"]}],"id":[{"id":"10.13039\/501100002767","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100017695","name":"Health Commission of Hunan Province","doi-asserted-by":"publisher","award":["D202303109387"],"award-info":[{"award-number":["D202303109387"]}],"id":[{"id":"10.13039\/100017695","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Hunan Provincial Administration of Traditional Chinese Medicine","award":["B2023090"],"award-info":[{"award-number":["B2023090"]}]},{"name":"the 2026 Changsha Outstanding Young Scientific and Technological Talents Cultivation Program"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["IJMS"],"abstract":"<jats:p>Chronic kidney disease (CKD) lacks highly specific early diagnostic biomarkers and safe, effective therapeutic options. To address this, we integrated multi-cohort transcriptomics, bioinformatics, and machine learning with reverse network pharmacology, molecular docking, molecular dynamics simulations, and in vivo experiments to identify candidate biomarkers associated with CKD and candidate therapeutic compounds for CKD. Our analyses of the GSE175759 training set and external validation datasets (GSE37171 and GSE66494) using differential expression and WGCNA indicated that CKD is characterized by immune-inflammatory activation and suppressed energy metabolism. Integration of PPI analysis with three machine learning algorithms identified JUN and C3 as candidate diagnostic genes. JUN was downregulated, whereas C3 was upregulated in CKD, both showing promising discriminatory performance in the analyzed datasets. Reverse screening identified Resveratrol and Triptolide as candidate active compounds, and molecular docking together with 100 ns molecular dynamics simulations supported stable binding to JUN\/C3 complexes. Given its superior safety profile, Resveratrol was selected for experimental validation. In an adenine-induced CKD rat model, Resveratrol improved renal function, reduced proteinuria, alleviated renal injury and fibrosis, and was associated with reduced activation of MAPK\/JNK-c-Jun signaling. In conclusion, this study identifies JUN and C3 as candidate biomarkers associated with CKD and suggests Resveratrol as a promising preclinical intervention candidate targeting the MAPK\/JNK-c-Jun axis, providing preliminary computational and preclinical evidence for biomarker discovery and natural medicine-based intervention in CKD.<\/jats:p>","DOI":"10.3390\/ijms27104252","type":"journal-article","created":{"date-parts":[[2026,5,12]],"date-time":"2026-05-12T07:49:09Z","timestamp":1778572149000},"page":"4252","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["An Integrated Machine-Learning and Reverse Network-Pharmacology Pipeline Reveals JUN\/C3 Candidate Biomarkers and an Anti-Fibrotic Mechanism of Resveratrol via MAPK\/JNK Signaling in Chronic Kidney Disease"],"prefix":"10.3390","volume":"27","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-5494-5523","authenticated-orcid":false,"given":"Yuan","family":"Cai","sequence":"first","affiliation":[{"name":"Hunan Academy of Chinese Medicine, Changsha 410013, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiaolong","family":"Feng","sequence":"additional","affiliation":[{"name":"Hunan Academy of Chinese Medicine, Changsha 410013, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0009-0007-9771-4868","authenticated-orcid":false,"given":"Xinru","family":"Tao","sequence":"additional","affiliation":[{"name":"Hunan Academy of Chinese Medicine, Changsha 410013, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Penghui","family":"Li","sequence":"additional","affiliation":[{"name":"Hunan Academy of Chinese Medicine, Changsha 410013, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jiaqin","family":"Liu","sequence":"additional","affiliation":[{"name":"Hunan Academy of Chinese Medicine, Changsha 410013, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ping\u2019an","family":"Liu","sequence":"additional","affiliation":[{"name":"Hunan Academy of Chinese Medicine, Changsha 410013, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mengxiong","family":"Xiao","sequence":"additional","affiliation":[{"name":"Experimental Research Center, China Academy of Chinese Medical Sciences, Beijing 100700, China"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1968","published-online":{"date-parts":[[2026,5,10]]},"reference":[{"key":"ref_1","unstructured":"GBD 2023 Chronic Kidney Disease Collaborators (2025). Global, regional, and national burden of chronic kidney disease in adults, 1990-2023, and its attributable risk factors: A systematic analysis for the Global Burden of Disease Study 2023. Lancet, 406, 2461\u20132482."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1007\/978-981-13-8871-2_1","article-title":"Prevalence and Disease Burden of Chronic Kidney Disease","volume":"1165","author":"Lv","year":"2019","journal-title":"Adv. Exp. Med. Biol."},{"key":"ref_3","doi-asserted-by":"crossref","unstructured":"Echefu, G., Stowe, I., Burka, S., Basu-Ray, I., and Kumbala, D. (2023). Pathophysiological concepts and screening of cardiovascular disease in dialysis patients. Front. Nephrol., 3.","DOI":"10.3389\/fneph.2023.1198560"},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"620","DOI":"10.1159\/000194455","article-title":"Increased cardiovascular risk associated with reduced kidney function","volume":"29","author":"Ryan","year":"2009","journal-title":"Am. J. Nephrol."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1038\/s41581-019-0248-y","article-title":"Targeting the progression of chronic kidney disease","volume":"16","author":"Lamas","year":"2020","journal-title":"Nat. Rev. Nephrol."},{"key":"ref_6","first-page":"497","article-title":"Immune Microenvironment Alterations and Identification of Key Diagnostic Biomarkers in Chronic Kidney Disease Using Integrated Bioinformatics and Machine Learning","volume":"17","author":"Shi","year":"2024","journal-title":"Pharmgenomics. Pers. Med."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"e188353","DOI":"10.1172\/JCI188353","article-title":"Chronic kidney disease enhances alternative pathway activity: A new paradigm","volume":"135","author":"Jalal","year":"2025","journal-title":"J. Clin. Investig."},{"key":"ref_8","doi-asserted-by":"crossref","unstructured":"Wang, X., Chen, J., Xu, J., Xie, J., Harris, D.C.H., and Zheng, G. (2021). The Role of Macrophages in Kidney Fibrosis. Front. Physiol., 12.","DOI":"10.3389\/fphys.2021.705838"},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"117079","DOI":"10.1016\/j.biopha.2024.117079","article-title":"The role of macrophages in fibrosis of chronic kidney disease","volume":"177","author":"Li","year":"2024","journal-title":"Biomed. Pharmacother."},{"key":"ref_10","doi-asserted-by":"crossref","unstructured":"Vasquez, F., Tiscornia, C., Lorca-Ponce, E., Aicardi, V., and Vasquez, S. (2025). Cardiorenal Syndrome: Molecular Pathways Linking Cardiovascular Dysfunction and Chronic Kidney Disease Progression. Int. J. Mol. Sci., 26.","DOI":"10.3390\/ijms26157440"},{"key":"ref_11","doi-asserted-by":"crossref","unstructured":"Alobaidi, S. (2025). Emerging Biomarkers and Advanced Diagnostics in Chronic Kidney Disease: Early Detection Through Multi-Omics and AI. Diagnostics, 15.","DOI":"10.3390\/diagnostics15101225"},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"1004","DOI":"10.1016\/j.kint.2023.03.009","article-title":"Perspectives on early detection of chronic kidney disease: The facts, the questions, and a proposed framework for 2023 and beyond","volume":"103","author":"Levin","year":"2023","journal-title":"Kidney. Int."},{"key":"ref_13","doi-asserted-by":"crossref","unstructured":"Dopiera\u0142a, M., Nitz, N., Kr\u00f3l, O., Wasicka-Przewo\u017ana, K., Schwermer, K., and Pawlaczyk, K. (2025). New and Emerging Biomarkers in Chronic Kidney Disease. Biomedicines, 13.","DOI":"10.3390\/biomedicines13061423"},{"key":"ref_14","doi-asserted-by":"crossref","unstructured":"Mohl, D.A., Lagies, S., Lonzer, A., Pf\u00e4ffle, S.P., Gro\u00df, P., Benka, M., J\u00e4ger, M., Huber, M.C., G\u00fcnther, S., and Plattner, D.A. (2025). On the Quest for Biomarkers: A Comprehensive Analysis of Modified Nucleosides in Ovarian Cancer Cell Lines. Cells, 14.","DOI":"10.3390\/cells14090626"},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1007\/s00441-023-03816-z","article-title":"The benefits and pitfalls of machine learning for biomarker discovery","volume":"394","author":"Ng","year":"2023","journal-title":"Cell Tissue Res."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1159\/000543640","article-title":"Personalized Care in CKD: Moving Beyond Traditional Biomarkers","volume":"149","author":"McDonnell","year":"2025","journal-title":"Nephron"},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1056\/NEJMoa2410316","article-title":"Alternative Complement Pathway Inhibition with Iptacopan in IgA Nephropathy","volume":"392","author":"Perkovic","year":"2025","journal-title":"N. Engl. J. Med."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"2284","DOI":"10.1016\/j.ekir.2023.08.033","article-title":"Clinical Safety and Efficacy of Pegcetacoplan in a Phase 2 Study of Patients with C3 Glomerulopathy and Other Complement-Mediated Glomerular Diseases","volume":"8","author":"Dixon","year":"2023","journal-title":"Kidney Int. Rep."},{"key":"ref_19","doi-asserted-by":"crossref","unstructured":"Yan, H., He, L., Lv, D., Yang, J., and Yuan, Z. (2024). The Role of the Dysregulated JNK Signaling Pathway in the Pathogenesis of Human Diseases and Its Potential Therapeutic Strategies: A Comprehensive Review. Biomolecules, 14.","DOI":"10.3390\/biom14020243"},{"key":"ref_20","doi-asserted-by":"crossref","unstructured":"Yang, F., Ozols, E., Ma, F.Y., Leong, K.G., Tesch, G.H., Jiang, X., and Nikolic-Paterson, D.J. (2021). c-Jun Amino Terminal Kinase Signaling Promotes Aristolochic Acid-Induced Acute Kidney Injury. Front. Physiol., 12.","DOI":"10.3389\/fphys.2021.599114"},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1681\/ASN.2006060604","article-title":"A pathogenic role for c-Jun amino-terminal kinase signaling in renal fibrosis and tubular cell apoptosis","volume":"18","author":"Ma","year":"2007","journal-title":"J. Am. Soc. Nephrol."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/j.ymthe.2016.08.001","article-title":"Therapeutic miR-21 Silencing Ameliorates Diabetic Kidney Disease in Mice","volume":"25","author":"Kaucsar","year":"2017","journal-title":"Mol. Ther."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"204","DOI":"10.7150\/ijbs.38841","article-title":"Transforming growth factor beta (TGF-\u03b2) is activated by the CtBP2-p300-AP1 transcriptional complex in chronic renal failure","volume":"16","author":"Zhou","year":"2020","journal-title":"Int. J. Biol. Sci."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"6727","DOI":"10.18632\/oncotarget.6797","article-title":"HDAC inhibitors suppress c-Jun\/Fra-1-mediated proliferation through transcriptionally downregulating MKK7 and Raf1 in neuroblastoma cells","volume":"7","author":"He","year":"2016","journal-title":"Oncotarget"},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"116759","DOI":"10.1016\/j.biopha.2024.116759","article-title":"Empagliflozin attenuates doxorubicin-induced cardiotoxicity by inhibiting the JNK signaling pathway","volume":"176","author":"Chang","year":"2024","journal-title":"Biomed. Pharmacother."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1007\/s00018-025-05688-8","article-title":"SGLT2 inhibitor empagliflozin ameliorates tubulointerstitial fibrosis in DKD by downregulating renal tubular PKM2","volume":"82","author":"Cai","year":"2025","journal-title":"Cell. Mol. Life Sci."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1002\/path.2228","article-title":"Glomerular and tubular induction of the transcription factor c-Jun in human renal disease","volume":"213","author":"Prakash","year":"2007","journal-title":"J. Pathol."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"1366","DOI":"10.1046\/j.1523-1755.2001.00941.x","article-title":"Tubular NF-kappaB and AP-1 activation in human proteinuric renal disease","volume":"60","author":"Mezzano","year":"2001","journal-title":"Kidney Int."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1016\/j.yexmp.2016.04.005","article-title":"Synergistic effects of c-Jun and SP1 in the promotion of TGF\u03b21-mediated diabetic nephropathy progression","volume":"100","author":"Gao","year":"2016","journal-title":"Exp. Mol. Pathol."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"2336128","DOI":"10.1080\/0886022X.2024.2336128","article-title":"Adenine-induced animal model of chronic kidney disease: Current applications and future perspectives","volume":"46","author":"Yang","year":"2024","journal-title":"Ren. Fail."},{"key":"ref_31","first-page":"F389","article-title":"Gene expression of growth-related proteins and ECM constituents in response to unilateral nephrectomy","volume":"262","author":"Nakamura","year":"1992","journal-title":"Am. J. Physiol."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1080\/13880209.2026.2616270","article-title":"Triptolide in renal disorders: Dual roles of therapeutic potential and nephrotoxicity: A narrative review","volume":"64","author":"Yan","year":"2026","journal-title":"Pharm. Biol."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"4389","DOI":"10.1073\/pnas.0700499104","article-title":"Triptolide is a traditional Chinese medicine-derived inhibitor of polycystic kidney disease","volume":"104","author":"Leuenroth","year":"2007","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1002\/biof.1584","article-title":"Resveratrol improves left ventricular remodeling in chronic kidney disease via Sirt1-mediated regulation of FoxO1 activity and MnSOD expression","volume":"46","author":"Li","year":"2020","journal-title":"BioFactors"},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1139\/cjpp-2020-0341","article-title":"Cyanidin-3-O-glucoside attenuates high glucose-induced podocyte dysfunction by inhibiting apoptosis and promoting autophagy via activation of SIRT1\/AMPK pathway","volume":"99","author":"Wang","year":"2021","journal-title":"Can. J. Physiol. Pharmacol."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"115588","DOI":"10.1016\/j.fct.2025.115588","article-title":"Resveratrol ameliorates streptozotocin induced renal inflammation and promotes autophagy by mediating the SphK1 pathway via Sirt1 in Wistar rats","volume":"203","author":"Feng","year":"2025","journal-title":"Food Chem. Toxicol."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"2845","DOI":"10.1016\/S0024-3205(01)01061-X","article-title":"Inhibitory effect of resveratrol on proteinuria, hypoalbuminemia and hyperlipidemia in nephritic rats","volume":"68","author":"Nihei","year":"2001","journal-title":"Life Sci."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"7097","DOI":"10.1074\/jbc.M109.038604","article-title":"SIRT1 suppresses activator protein-1 transcriptional activity and cyclooxygenase-2 expression in macrophages","volume":"285","author":"Zhang","year":"2010","journal-title":"J. Biol. Chem."}],"container-title":["International Journal of Molecular Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1422-0067\/27\/10\/4252\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,12]],"date-time":"2026-05-12T08:03:39Z","timestamp":1778573019000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1422-0067\/27\/10\/4252"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,10]]},"references-count":38,"journal-issue":{"issue":"10","published-online":{"date-parts":[[2026,5]]}},"alternative-id":["ijms27104252"],"URL":"https:\/\/doi.org\/10.3390\/ijms27104252","relation":{},"ISSN":["1422-0067"],"issn-type":[{"value":"1422-0067","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,5,10]]}}}